Form 4 for NUTX Nutex Health Inc.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-15 · accession 0001486189-23-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-16 | 2023-11-15 | NUTX | DeTillio Joshua | COO | P - Purchase | $0.24 | +140.0K | 140.0K | New | +$33.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | P | A | 140,000 | $0.24 | 140,000 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.2269 to $0.2491 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. (F2) The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship. |